Rituximab Offlabel denied for missing prior authorization by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for rituximab offlabel are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied This Rituximab Claim: Prior Authorization Required

A prior-authorization-required denial means the claim was submitted — or the drug was dispensed — before BCBS issued an authorization. For off-label rituximab, prior authorization is almost universally required because it is a high-cost specialty biologic used for conditions BCBS must evaluate case by case. The denial is not necessarily a clinical judgment; it may simply reflect a process failure where authorization was not obtained in advance.

If authorization was not sought beforehand, the path forward is typically to apply for prior authorization now and, if denied on clinical grounds, appeal that decision. If authorization was sought and improperly denied or delayed, you can appeal the coverage denial directly.

## Your Federal Appeal Rights

• Internal appeal: Under ERISA §503 (job-based plans) you may appeal any adverse benefit determination, including a denial based on lack of prior authorization, as a medical-necessity question.
• External review: Under ACA §2719, once internal appeals are exhausted, you may request IRO review within approximately four months of the final internal denial.
• Expedited option: If your clinical situation is urgent, request expedited prior-authorization review (typically 72-hour turnaround) and note the urgency in writing.
• Retroactive authorization: For situations where treatment could not wait, some BCBS plans allow retroactive authorization requests; check your plan's Evidence of Coverage.

## Documentation to Gather

1. Diagnosis confirmation — specialist notes and supporting diagnostic records for the specific condition being treated. 2. Prescriber medical-necessity letter — addressing each of BCBS's prior-authorization criteria for rituximab off-label use, as listed in the current coverage policy. 3. Prior-treatment history — a complete chronological list of agents tried previously, with start/stop dates and documented outcomes, particularly if BCBS's policy requires step-therapy failures. 4. Clinical severity documentation — objective chart evidence (disease activity, organ involvement, functional impairment) demonstrating why treatment was necessary and, if relevant, why it could not wait for a standard authorization timeline. 5. Evidence of prescriber's submission — if prior authorization was requested and the denial was a process error on BCBS's part, include fax confirmations, portal submission records, or call logs.

## Criteria-Mapping Structure

Obtain the current BCBS prior-authorization criteria for rituximab and your specific diagnosis. For each listed criterion, prepare a concise answer citing the relevant chart document or letter. Your prescriber's letter should walk through the criteria in the same order they appear in the policy, making the reviewer's job as simple as possible.